Kidney drug trial for infants and toddlers halted early
NCT ID NCT04064827
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a liquid medicine called paricalcitol in children aged 0 to 9 years with severe kidney failure who are on dialysis. The goal was to see if it safely lowers high parathyroid hormone levels, a common complication. The trial was stopped early after enrolling only 2 participants, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arkansas Children's Hospital /ID# 225417
Little Rock, Arkansas, 72202, United States
-
Atrium Health Wake Forest Baptist Medical Center /ID# 266045
Winston-Salem, North Carolina, 27157, United States
-
Augusta University Medical Center /ID# 252149
Augusta, Georgia, 30912-0004, United States
-
Boston Children's Hospital /ID# 162863
Boston, Massachusetts, 02115, United States
-
Children's Hospital of Philadelphia - Main /ID# 213802
Philadelphia, Pennsylvania, 19104-4319, United States
-
Childrens National Medical Center /ID# 225991
Washington D.C., District of Columbia, 20010-2916, United States
-
Duplicate_Levine Children's Specialty Center- Charlotte /ID# 216057
Charlotte, North Carolina, 28203-5866, United States
-
Emory University /ID# 140665
Atlanta, Georgia, 30322-1014, United States
-
Holtz Childrens Hospital, University of Miami /ID# 225636
Miami, Florida, 33136-1005, United States
-
Nicklaus Children's Hospital /ID# 210517
Miami, Florida, 33155-3009, United States
-
School of Medicine University of Puerto Rico-Medical Science Campus /ID# 140663
San Juan, 00935, Puerto Rico
-
Seattle Children's Hospital /ID# 162861
Seattle, Washington, 98105, United States
-
Stanford University School of Medicine - Redwood City /ID# 252150
Redwood City, California, 94063, United States
-
University of Texas Southwestern Medical Center /ID# 210495
Dallas, Texas, 75390-7208, United States
-
University of Utah /ID# 140669
Salt Lake City, Utah, 84112-5500, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Plastics in dialysis: could they add toxins to Children's blood?
- Can a newer heart failure drug protect kidneys better than an older one?
- A urine test strip that could transform kidney diet care?
- A softer path for kidney disease: could palliative care ease the burden?
- Thousands of kidney patients tracked to unlock better disease management
- Can a Home-Based program help kidney patients get stronger before transplant?